Development and application of a high-throughput microneutralization assay: Lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors

Transfusion

Volumn 52, Issue 2, 2012, Pages 332-342

  Zhou, Yanchen ^a,b,c,d,e   Steffen, Imke ^a,b,c,d,e   Montalvo, Leilani ^a,b,c,d,e   Lee, Tzong Hae ^a,b,c,d,e   Zemel, Reeve ^a,b,c,d,e   Switzer, William M ^a,b,c,d,e   Tang, Shaohua ^a,b,c,d,e   Jia, Hongwei ^a,b,c,d,e   Heneine, Walid ^a,b,c,d,e   Winkelman, Valerie ^a,b,c,d,e   Tailor, Chetankumar S ^a,b,c,d,e   Ikeda, Yasuhiro ^a,b,c,d,e   Simmons, Graham ^a,b,c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CREATIVE TESTING SOLUTIONS   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR; VIRUS ANTIBODY;

ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACACA; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PSEUDOTYPING; VIRUS DETECTION; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; WESTERN BLOTTING; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLOOD DONORS; CELL LINE, TUMOR; FEMALE; HEK293 CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LEUKEMIA VIRUS, MURINE; MACACA MULATTA; MALE; MICE; MICROCHEMISTRY; NEUTRALIZATION TESTS; NIH 3T3 CELLS; RETROVIRIDAE INFECTIONS; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 84862907537     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03519.x     Document Type: Article

References (50)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL,. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006; 2: e25.
2. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR,. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A 2009; 106: 16351-6.
3. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, Schlomm T,. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 2008; 43: 277-83.
4. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N,. Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 2009; 6: 92.
5. Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, McLaren S, Pillay D, Futreal A, Garson JA, Pybus OG, Kellam P, Towers GJ,. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010; 7: 111.
6. Garson JA, Kellam P, Towers GJ,. Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology 2011; 8: 13.
7. Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ Jr, Coffin JM, Pathak VK,. Recombinant origin of the retrovirus XMRV. Science 2011; 333: 97-101.
8. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA,. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009; 326: 585-9.
9. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, Collier D, Wessely S, Cleare A,. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS ONE 2010; 5: e8519.
10. Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S, Hagan S, Gow JW, Mattes FM, Breuer J, Kerr JR, Stoye JP, Bishop KN,. Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 2010; 7: 10.
11. Kunstman KJ, Bhattacharya T, Flaherty J, Phair JP, Wolinsky SM,. Absence of xenotropic murine leukemia virus-related virus in blood cells of men at risk for and infected with HIV. AIDS 2010; 24: 1784-5.
12. Switzer WM, Jia H, Hohn O, Zheng H, Tang S, Shankar A, Bannert N, Simmons G, Hendry RM, Falkenberg VR, Reeves WC, Heneine W,. Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 2010; 7: 57.
13. van Kuppeveld FJ, de Jong AS, Lanke KH, Verhaegh GW, Melchers WJ, Swanink CM, Bleijenberg G, Netea MG, Galama JM, van der Meer JW,. Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 2010; 340: c1018.
14. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J Jr, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA,. No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 2011; 333: 94-7.
15. Shin CH, Bateman L, Schlaberg R, Bunker AM, Leonard CJ, Hughen RW, Light AR, Light KC, Singh IR,. Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome. J Virol 2011; 85: 7195-202.
16. Silverman RH, Das Gupta J, Lombardi VC, Ruscetti FW, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Mikovits JA,. Partial retraction. Science 2011; 334: 176.
17. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, Hackett J Jr, Tang N, Switzer WM, Heneine W, Hewlett IK, Zhao J, Lo SC, Alter HJ, Linnen JM, Gao K, Coffin JM, Kearney MF, Ruscetti FW, Pfost MA, Bethel J, Kleinman S, Holmberg JA, Busch MP,. Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science 2011; 334: 814-7.
18. Chanas AC, Johnson BK, Simpson DI,. Antigenic relationships of alphaviruses by a simple micro-culture cross-neutralization method. J Gen Virol 1976; 32: 295-300.
19. Assays for neutralizing antibody to influenza viruses. Report of an informal scientific workshop, Dresden, 18-19 March 2003. Wkly Epidemiol Rec 2003; 78: 290-3.
20. Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, Hien VM, Ha do Q, de Jong M, Zambon M, Takeuchi Y, Weiss RA,. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respi Viruses 2007; 1: 105-12.
21. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, Bhosle SM, Liotta D, Hunter E, Marshall FF, Ly H, Molinaro RJ, Blackwell JL, Petros JA,. XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 2010; 75: 755-61.
22. Zhou Y, Agudelo J, Lu K, Goetz DH, Hansell E, Chen YT, Roush WR, McKerrow J, Craik CS, Amberg SM, Simmons G,. Inhibitors of SARS-CoV entry-identification using an internally-controlled dual envelope pseudovirion assay. Antiviral Res 2011; 92: 187-94.
23. Tailor CS, Nouri A, Lee CG, Kozak C, Kabat D,. Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci U S A 1999; 96: 927-32.
24. Tailor CS, Nouri A, Kabat D,. Cellular and species resistance to murine amphotropic, gibbon ape, and feline subgroup C leukemia viruses is strongly influenced by receptor expression levels and by receptor masking mechanisms. J Virol 2000; 74: 9797-801.
25. Wang H, Paul R, Burgeson RE, Keene DR, Kabat D,. Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor. J Virol 1991; 65: 6468-77.
26. Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, Peng KW, Barry MA, Ikeda Y,. Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. J Virol 2011; 85: 1205-13.
27. Qiu X, Swanson P, Luk KC, Tu B, Villinger F, Das Gupta J, Silverman RH, Klein EA, Devare S, Schochetman G, Hackett J Jr,. Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology 2010; 7: 68.
28. Gilbert JM, Bates P, Varmus HE, White JM,. The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein. J Virol 1994; 68: 5623-8. (Pubitemid 24258575)
29. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P,. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 2005; 102: 11876-81. (Pubitemid 41170818)
30. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P,. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A 2004; 101: 4240-5. (Pubitemid 38405913)
31. Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P,. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 2002; 76: 2518-28. (Pubitemid 34150720)
32. Salvador B, Zhou Y, Michault A, Muench MO, Simmons G,. Characterization of Chikungunya pseudotyped viruses: identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein. Virology 2009; 393: 33-41.
33. Connor RI, Chen BK, Choe S, Landau NR,. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995; 206: 935-44.
34. Amberg SM, Netter RC, Simmons G, Bates P,. Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide. J Virol 2006; 80: 353-9.
35. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM, Kingsman AJ,. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-33.
36. Satterfield BC, Garcia RA, Jia H, Tang S, Zheng H, Switzer WM,. Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses. Retrovirology 2011; 8: 12.
37. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH,. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A 2007; 104: 1655-60. (Pubitemid 46214646)
38. Steffen I, Tyrrell DL, Stein E, Montalvo L, Lee TH, Zhou Y, Lu K, Switzer WM, Tang S, Jia H, Hockman D, Santer DM, Logan M, Landi A, Law J, Houghton M, Simmons G,. No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome. PLoS ONE 2011; 6: e27870.
39. Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, Wang R, Alter HJ,. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 2010; 107: 15874-9.
40. Kearney MF, Lee K, Bagni RK, Wiegand A, Spindler J, Maldarelli F, Pinto PA, Linehan WM, Vocke CD, Delviks-Frankenberry KA, deVere White RW, Del Prete GQ, Mellors JW, Lifson JD, KewalRamani VN, Pathak VK, Coffin JM, Le Grice SF,. Nucleic acid, antibody, and virus culture methods to detect xenotropic MLV-related virus in human blood samples. Adv Virol 2011;article ID 272193.
41. Sakuma T, De Ravin SS, Tonne JM, Thatava T, Ohmine S, Takeuchi Y, Malech HL, Ikeda Y,. Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein. Hum Gene Ther 2010; 21: 1665-73.
42. Cvitanich C, Pallisgaard N, Nielsen KA, Hansen AC, Larsen K, Pihakaski-Maunsbach K, Marcker KA, Jensen EO,. CPP1, a DNA-binding protein involved in the expression of a soybean leghemoglobin c3 gene. Proc Natl Acad Sci U S A 2000; 97: 8163-8. (Pubitemid 30460790)
43. Daugherty SA, Henry BE, Peterson DL, Swarts RL, Bastien S, Thomas RS,. Chronic fatigue syndrome in northern Nevada. Rev Infect Dis 1991; 13 Suppl 1: S39-44.
44. Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB,. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA 1987; 257: 2297-302. (Pubitemid 17059601)
45. DeFreitas E, Hilliard B, Cheney PR, Bell DS, Kiggundu E, Sankey D, Wroblewska Z, Palladino M, Woodward JP, Koprowski H,. Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci U S A 1991; 88: 2922-6. (Pubitemid 21916532)
46. Nielsen K, Bryson YJ,. Diagnosis of HIV infection in children. Pediatr Clin North Am 2000; 47: 39-63. (Pubitemid 30108790)
47. Suligoi B, Rodella A, Raimondo M, Regine V, Terlenghi L, Manca N, Casari S, Camoni L, Salfa MC, Galli C,. Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays. J Clin Microbiol 2011; 49: 2610-3.
48. Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, Weiss RA,. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis 2005; 11: 411-6. (Pubitemid 40315726)
49. Tuke PW, Tettmar KI, Tamuri A, Stoye JP, Tedder RS,. PCR master mixes harbour murine DNA sequences. Caveat emptor! PLoS ONE 2011; 6: e19953.
50. Katzourakis A, Hue S, Kellam P, Towers GJ,. Phylogenetic analysis of murine leukemia virus sequences from longitudinally sampled chronic fatigue syndrome patients suggests PCR contamination rather than viral evolution. J Virol 2011; 85: 10909-13.